AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05584202 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 0.9% sodium chloride
Study NCT06748404 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tricalm Hydrogel
Description: TriCalm Hydrogel® is a topical gel that allows rapid administration to areas of the skin. TriCalm Hydrogel® is available over-the-counter and contains the active ingredient, aluminum acetate 0.2%, and inactive ingredient, strontium chloride hexahydrate.
Study NCT06748404 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tricalm Hydrogel
Description: TriCalm Hydrogel® is a topical gel that allows rapid administration to areas of the skin. TriCalm Hydrogel® is available over-the-counter and contains the active ingredient, aluminum acetate 0.2%, and inactive ingredient, strontium chloride hexahydrate.
Study NCT06748404 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Triamcinolone acetonide 0.1% cream
Description: Triamcinolone acetonide 0.1% cream is a topical steroid cream that will be applied directly to the skin.
Study NCT05811351 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: JNJ-81201887
Description: JNJ-81201887 will be administered as intravitreal injection.
Study NCT05811351 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Prednisone
Description: Prednisone will be administered as oral capsule.
Study NCT05811351 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Placebo
Description: Prednisone matching placebo will be administered as oral capsule.
Study NCT05811351 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Triamcinolone
Description: Triamcinolone (corticosteroid injection) periocular injection will be administered as per local practice.
Study NCT05811351 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Sham Procedure
Description: Sham injections matching to single JNJ-81201887 injection and matching to corticosteroid (triamcinolone) periocular injection will be administered.
Study NCT06757673 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Robot-Assisted Therapy using Kebbi Air
Description: Participants in this group will engage with the Kebbi Air smart robot, which is programmed with interactive scripts designed to enhance social-emotional regulation skills. The intervention includes weekly 30-minute sessions over a 12-week period, where the robot simulates real-life social scenarios and provides verbal and visual responses to guide participants in developing emotional and social skills. Occupational therapists will supervise these sessions to ensure the appropriateness of interactions and provide additional support as needed.
Study NCT06757673 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Sensory Integration Therapy
Description: Participants in this group will receive traditional sensory integration therapy guided by occupational therapists. The therapy focuses on improving sensory processing and emotional regulation through structured activities targeting visual, auditory, and tactile stimuli. Each session is conducted weekly, lasting 30 minutes, for a total of 12 weeks. The therapy aims to help children adapt to sensory inputs and enhance their ability to engage in social interactions and manage emotions effectively.
Study NCT06758830 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Radiation Therapy
Description: Radiation therapy (RT) is administered at a dose of 2 Gy per day for a total dose of 50 Gy delivered to the pelvis. This is done throughout 5 to 6 weeks.
Study NCT06758830 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Chemoradiotherapy
Description: Capecitabine: 825 mg/m² twice daily, prescribed 1-5 days per week, for 5 weeks during RT.~Or Bolus 5-FU regimen: 5-fluorouracil (5-FU) 400 mg/m2/day intravenously, administered on days 1-4 and 33-35. Calcium folinate (folinic acid) 20 mg/m2/day intravenously on days 1-4 and 33-35.
Study NCT06758830 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Consolidation Chemotherapy
Description: XELOX: Oxaliplatin 130 mg/m² (day 1) + capecitabine 1000 mg/m² (days 1-14), every 3 weeks for 4 cycles.~Or FOLFOX: Oxaliplatin - 85 mg/m2 intravenously (2-hour infusion), drip for 1 day. Calcium folinate (folinic acid) - 400 mg/m2/d. intravenously (2-hour infusion), started on day 1. F(5-fluorouracil) - 400 mg/m2/d. intravenously (bolus), started on day 1. Repeat every 2 weeks for 6 times.
Study NCT06758830 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Surgery
Description: Transabdominal Resection: Abdominoperineal resection, low anterior resection, or coloanal anastomosis using total mesorectal excision.
Study NCT06758830 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Surgery
Description: Transabdominal Resection: Abdominoperineal resection, low anterior resection, or coloanal anastomosis using total mesorectal excision.
Study NCT06758830 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Part two
Description: Standard treatment protocols and follow-up procedures are implemented in clinical practice.
Study NCT06758830 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Adjuvant treatment
Description: If indicated, adjuvant therapy will be administered as usual in clinical practice.
Study NCT06760234 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: No Interventions
Description: The high-throughput extraction of quantitative image features from medical images
Study NCT06760234 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: No Interventions
Description: Immunohistochemical analysis
Study NCT06766058 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Carrier oil
Description: Inhaler stick containing 2 drops of carrier oil.
Study NCT06766058 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Asian plant extract blend
Description: Inhaler stick containing 2 drops of Asian plant extract blend.
Study NCT06766799 — intervention group
Intervention type: DEVICE
Intervention: Rebound and Applanation Tonometer
Description: Measurement of Intraocular Pressure
Study NCT06765200 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Self-administered psychosocial intervention delivered via smartphone.
Description: The treatment includes a smartphone-based psychosocial program designed to improve the quality of life of adolescents with chronic pain.
Study NCT06765785 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: CTCA
Description: Screening CTCA will be performed in the experimental arm after 1:1 randomisation using sealed envelope technique
Study NCT06765343 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Plaque disclosing agent
Description: Dye agent binding to oral biofilm and plaque for visual detection
Study NCT06765343 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Guided Biofilm Therapy
Description: Utilisation of a air-polishing device conveying a jet of air, water and erythritol powder for plaque debridement on dental surfaces, followed by calculus removal with an ultrasonic scaler
Study NCT06765343 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Ultrasonic debridement and polishing
Description: Removal of plaque and calculus with an ultrasonic scaler, followed by surface polishing with a rubber cup and abrasive paste
Study NCT06765343 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Ultrasonic debridement and polishing
Description: Removal of plaque and calculus with an ultrasonic scaler, followed by surface polishing with a rubber cup and abrasive paste
Study NCT06766838 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: 1. Conventional dissection technique (group A) :
Description: In this group, circumcision is performed by the dorsal slit technique. A slit is made dorsally to the level of about 5 mm from the coronal sulcus, and the redundant foreskin and mucosa were excised circumferentially. Hemostasis is secured with ligation , and the cut edges are sutured with absorbable suture. Then, dressing is applied.
Study NCT06766838 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: 2. Bone cutting forceps technique (Group B)
Description: Two mosquito forceps are used to grasp the foreskin. The glans penis is squeezed back to avoid its injury. After that, bone cutting forceps is applied to the foreskin for 3 minutes, at the level of the mark, then the foreskin is excised by scalpel at the same level. Bleeding points are ligated and the cut edges are sutured with absorbable suture. Then, a dressing is applied
Study NCT06766838 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: 3. Electro-cauterization (bipolar) assisted circumcision (Group C)
Description: The skin is held by two hemostats to elevate the foreskin, and then the kocher clamp applied at the level of the skin to be removed for circumcision. Excess foreskin will be cut by scissor with hemostasis by bipolar cauterization.~The skin retracted proximally after that to expose the glans. Sutures are made if there is separation between the skin and the mucous membrane.
Study NCT06766838 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: 4. Thermal cauterization assisted circumcision (Group D)
Description: The skin is held by two hemostats to elevate the foreskin, and then the kocher clamp applied at the level of the skin to be removed for circumcision. Excess foreskin will be cut by thermal cauterization. The skin retracted proximally after that to expose the glans. Sutures are made if there is separation between the skin and the mucous membrane.
Study NCT06766838 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: 5. Gomco clamp technique (Group E):
Description: The prepuce is grasped using two hemostats applied at 2 and 10 o'clock. A dorsal slit at 12 o'clock is made, appropriate-sized bell is placed over the glans, and the foreskin is brought over its top. The string is placed around the foreskin and the Plastibell device at the level of the mark in a groove that acted as the string placement guide. The string is then tightened and tied in a simple square knot. The excess foreskin is trimmed from around the bell using iris scissors. The handle is then broken off the device
Study NCT06766838 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: 6. Plastibell device technique (Group F):
Description: The prepuce is grasped using two hemostats applied at 2 and 10 o'clock. A dorsal slit at 12 o'clock is made, appropriate-sized bell is placed over the glans, and the foreskin is brought over its top. The string is placed around the foreskin and the Plastibell device at the level of the mark in a groove that acted as the string placement guide. The string is then tightened and tied in a simple square knot. The excess foreskin is trimmed from around the bell using iris scissors. The handle is then broken off the device
Study NCT06766968 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Graduated Compression Stocking: 1 month using
Description: Class 2 (RAL-GZ 387 standard: 23-32 mm Hg at the ankle level) above-knee graduated compression stockings
Study NCT06766968 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Graduated Compression Stocking: 1 week using
Description: Class 2 (RAL-GZ 387 standard: 23-32 mm Hg at the ankle level) above-knee graduated compression stockings
Study NCT06765512 — intervention group
Intervention type: OTHER
Intervention: use of deep learning and automated machine learning to diagnose and classify adenomyosis
Description: Vertex AI Vision V1 software will be used as an automated machine learning tool and Pytorch 2.5 as deep learning framework. The complete set of reviewed, formatted and labelled images will be uploaded and split manually into two different datasets in 9:1 ratio; 90% of the selected images will be used as training dataset (training + validation) and 10% as test dataset.
Study NCT06405828 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: ACCESS Supportive Care
Description: ACCESS Supportive Care includes:~1. Coaching sessions: 6 one-hour weekly Community Navigator led supportive and early palliative care health coaching sessions. Sessions will be hybrid (in-person or virtual) per participant preference.~2. Monthly check-in: Monthly check-ins (\~5-10 minutes) about their supportive care and social determinants of health needs over 16 weeks.~3. Scheduling of outpatient supportive oncology appointment if interested.~4. Community linkage: Warm hand offs and connection to community resources to enhance access to support groups, educational workshops, and healthy lifestyle services.
Study NCT06405828 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Phone sessions
Description: 6 weekly phone sessions, approximately 10 minutes in length each, to review breast cancer and supportive and palliative care resources in NYC and online. The 6 weekly phone sessions will include the topics discussed in the intervention arm but will be informational in nature. The phone sessions will be followed by monthly check-ins (\~5 minutes) to review and answer questions about the resources for the duration of 16 weeks.
Study NCT04429555 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ibudilast
Description: 50 mg (5 x 10 mg capsules) twice daily for 7 days
Study NCT04429555 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 0 mg (5 matching capsules) twice daily for 7 days
Study NCT06766331 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Integrated care
Description: Receipt of infectious diseases laboratory testing and/or PrEP for HIV within a single substance use disorder clinic appointment.
Study NCT06765876 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Autologous CAR123 T lymphocytes
Description: Anti-CD123 Chimeric Antigen Receptor (CAR) T-Cells (CART123)
Study NCT06767813 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TQB2868 injection+Gemcitabine injection+ Albumin paclitaxel injection+ Anlotinib capsules
Description: TQB2868 injection is an anti-PD 1/growth factor (GF)-β Receptor Type II (TGF-βRII) bifunctional fusion protein.
Study NCT06762860 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dexmedetomidine
Description: label sticker
Study NCT06762860 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Granisetron
Description: label sticker
Study NCT06762860 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: label sticker
Study NCT06765915 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Avapritinib
Description: After allo-HSCT, CBF-AML patients who have kit mutation would receive avapritinib for maintenance therapy.
Study NCT06766760 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Da Vinci SP Surgical System, Model SP1098
Description: The da Vinci SP Surgical System is intended to assist in the accurate control of the da Vinci SP endoscope and instruments during minimally invasive endoscopic abdominopelvic, thoracoscopic, transoral otolaryngology, and breast surgical procedures. The system is indicated for adult use. It is intended to be used by trained physicians in an operating room environment.
Study NCT06766929 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: VSA012
Description: subcutaneous injection
Study NCT06766929 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: subcutaneous injection
Study NCT06767176 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Beetroot Juice (Beet-It Stamina Shot) & Supervised Exercise Training
Description: 7 doses, taken daily, 70 ml shots, consumed in the morning before the start of fasting
Study NCT06766565 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: QYJD Compound Preparation
Description: The intervention group was treated with 2 capsules (g) of expelling stasis and QYJD compound preparation orally for 4 days before thoracoscopic radical surgery for lung cancer, 3 times a day. The blank control group had no oral drug treatment before surgery.
Study NCT06765720 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Intermittent feeding method with nasogastric tube
Description: 30 Minutes Before Feeding: No invasive procedures will be performed 30 minutes before the daily 1:00 PM feeding.~5 Minutes Before Feeding: To measure physiological variables, the pulse oximeter probe will be attached to the baby's foot. Oxygen saturation and heart rate will be measured for 2 minutes before feeding.~Feeding Phase: Measurement values will be taken from the pulse oximeter during feeding.~Post-Feeding Phase: Any interventions that could affect physiological values will be prevented, and oxygen saturation and heart rate will continue to be measured during the 2-minute period. The baby will be scored using the Early Feeding Skills Assessment Tool.
Study NCT06765720 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Intermittent feeding method with orogastric tube
Description: 30 Minutes Before Feeding: No invasive procedures will be performed 30 minutes before the daily 1:00 PM feeding.~5 Minutes Before Feeding: To measure physiological variables, the pulse oximeter probe will be attached to the baby's foot. Oxygen saturation and heart rate will be measured for 2 minutes before feeding.~Feeding Phase: Measurement values will be taken from the pulse oximeter during feeding.~Post-Feeding Phase: Any interventions that could affect physiological values will be prevented, and oxygen saturation and heart rate will continue to be measured during the 2-minute period. The baby will be scored using the Early Feeding Skills Assessment Tool.
Study NCT06768047 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Microporous tape
Description: Microporous tape is a dressing tape that was discovered to have scar modulating effects. It is made up of a conformable, inextensible, nonwoven fabric manufactured from 100% viscose and coated with a layer of acrylic adhesive. It is cheap, cost-effective, readily available, and relatively affordable for post surgical patients.
Study NCT06768047 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Tradition physical therapy
Description: Tradition physical therapy as stretching exercises and deep friction massage, Stretching is a form of physical exercise in which a specific muscle or tendon (or muscle group) is deliberately expanded and flexed in order to improve the muscle's felt elasticity and achieve comfortable muscle tone. The result is a feeling of increased muscle control, flexibility, and range of motion.~Deep friction massage also known as cross friction massage, is a specific connective tissue massage which maintain the mobility within the soft tissue structures of ligament, tendon, and muscle, and prevent adherent scars from forming.
Study NCT06768047 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Tradition physical therapy
Description: Tradition physical therapy as stretching exercises and deep friction massage, Stretching is a form of physical exercise in which a specific muscle or tendon (or muscle group) is deliberately expanded and flexed in order to improve the muscle's felt elasticity and achieve comfortable muscle tone. The result is a feeling of increased muscle control, flexibility, and range of motion.~Deep friction massage also known as cross friction massage, is a specific connective tissue massage which maintain the mobility within the soft tissue structures of ligament, tendon, and muscle, and prevent adherent scars from forming.
Study NCT06769542 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Experimental (micro teaching)
Description: The experimental group was taught using the micro-teaching method for 8 weeks. Psychomotor skills for drug administration were performed on models. Video recordings were taken while the students were performing the skills. These videos were evaluated by the instructor and the students and the students were given the opportunity to see their own mistakes. During 8 weeks, each student was given the opportunity to perform the applications and evaluate themselves. In addition, activities for drug applications were carried out with students within the scope of small group work. Micro teaching with 4 groups of 8 students was applied for 8 weeks.
Study NCT06768411 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: PEG-rhGH
Description: 1= 0.2mg/kg/week Initial doses of PEG-rhGH 2=0.22mg/kg/week Initial doses of PEG-rhGH
Study NCT06768411 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: GnRHa
Description: 1. pubertal children of short stature without GnRHa treatment~2. pubertal children of short stature with GnRHa treatment
Study NCT06766435 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: i-STAT TBI Test
Description: The Abbott i-STAT TBI test result is shared with the enrolled patient and treating clinicians.
Study NCT06766890 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: WeJoy+WeHop
Description: School-based CBT (WeJoy) comprises six weekly sessions on psychoeducation, cognitive restructuring, behavioural activation, emotional regulation, and self-monitoring. Exergaming on the interactive floor (WeHop) can gain a sense of autonomy, competence, and relatedness to help them regulate their emotions and maintain positive behaviours according to the Self-Determination Theory. Children participate in the interactive floor games by stepping on various targets and moving in response to the game's rules. Combining task division, cooperation, and taking turns constitutes the collaboration mechanism.
Study NCT04980378 — intervention group
Intervention type: DEVICE
Intervention: Simplify Disc
Description: The Simplify Disc is a cervical artificial disc manufactured from polyether ether ketone (PEEK) endplates and a mobile, zirconia-toughened alumina ceramic core.
Study NCT05842447 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: 367 mg Pomanox group
Description: Treatment with 367 mg Pomanox®P30 during 12 weeks
Study NCT05842447 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: 700 mg Pomanox group
Description: Treatment with 700 mg Pomanox®P30 during 12 weeks
Study NCT05842447 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Control group
Description: Treatment with maltodextrin during 12 weeks